newsfilter
← Latest News
PR Newswire·

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

HCTI
  • Healthcare Triangle, Inc. (HCTI) signed a non-binding Letter of Intent to acquire a 51% equity stake in CosmoAesthetics Pty Ltd, operating as CosmoInnovations.
  • The proposed total consideration is US $23.5 million, structured via cash, equity, & performance-linked milestones over three years.
  • CosmoInnovations holds a portfolio of 27 granted international patents & 61 pending patent applications.
  • The acquired company targets over US $50 million in cumulative revenue over the first three years post-acquisition.
  • The transaction transitions HCTI from a healthcare IT services provider into a product-led healthcare innovation platform.
  • CosmoInnovations' technology portfolio covers skincare, photobiomodulation, respiratory wellness, oral health, pain management, & transdermal delivery.
  • Manufacturing of CosmoInnovations' CirQlight™ LED technology is handled exclusively by Shenzhen RedV Medical Equipment Co., Ltd., which completed FDA establishment registration & device listing for fiscal year 2025.
  • CosmoInnovations is a JLABS alumni company that completed a four-year residency at JLABS Shanghai.
  • Strategic objectives include integrating AI, expanding into consumer health markets, & establishing recurring revenue streams through consumables & licensing.
  • HCTI will immediately initiate independent intellectual property & financial due diligence to verify the patent portfolio status & valuation.
  • External recognition includes selection for the 2026 MedTech Innovator Asia Pacific program & a finalist position in the BeautyMatter Awards.
  • The acquisition remains subject to the completion of definitive agreements, satisfactory due diligence, & regulatory approvals.